These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31432246)

  • 1. [Cannabis medicines in pain management : Interim analysis of the survey accompanying the prescription of cannabis-based medicines in Germany with regard to pain as primarily treated symptom].
    Cremer-Schaeffer P; Schmidt-Wolf G; Broich K
    Schmerz; 2019 Oct; 33(5):415-423. PubMed ID: 31432246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Three years of cannabis as medicine-preliminary results of the survey accompanying the prescription of medical cannabis in Germany].
    Schmidt-Wolf G; Cremer-Schaeffer P
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Mar; 64(3):368-377. PubMed ID: 33564897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interim analysis of the survey accompanying insurance-covered prescriptions of cannabis-based medicines in Germany].
    Schmidt-Wolf G; Cremer-Schaeffer P
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Jul; 62(7):845-854. PubMed ID: 31143965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cannabis-based medicines for chronic pain: indications, selection of drugs, effectiveness and safety : Experiences of pain physicians in Saarland].
    Bialas P; Drescher B; Gottschling S; Juckenhöfel S; Konietzke D; Kuntz W; Kühne-Adler I; Merl-Ripplinger H; Preisegger D; Schneider K; Strauß M; Welsch P; Häuser W
    Schmerz; 2019 Oct; 33(5):399-406. PubMed ID: 31201550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cannabis for medical purposes : Impact of the law of 6 March 2017 on physicians].
    Cremer-Schaeffer P; Knöss W; Broich K
    Schmerz; 2019 Oct; 33(5):378-383. PubMed ID: 31243538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of cannabis-based drugs in pain and palliative medicine : Joint online questionnaire conducted by the Professional Association of Physicians and Psychotherapists in Pain and Palliative Medicine in Germany (BVSD), the German Pain Society, and the German Society for Pain Medicine (DGS)].
    Gastmeier K
    Schmerz; 2019 Oct; 33(5):408-414. PubMed ID: 31444575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cannabis-derived medicines for the treatment of chronic pain : Problems resulting from medical appraisals in the experience of the Medical Advisory Board of the Statutory Health Insurance Funds North].
    Heidbreder M; van Treeck B
    Schmerz; 2019 Oct; 33(5):437-442. PubMed ID: 31531729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.
    Krcevski-Skvarc N; Wells C; Häuser W
    Eur J Pain; 2018 Mar; 22(3):440-454. PubMed ID: 29134767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medicinal cannabis and cannabis-based medication: an appeal to physicians, journalists, health insurances, and politicians for their responsible handling].
    Häuser W; Hoch E; Petzke F; Thomasius R; Radbruch L; Batra A; Sommer C; Havemann-Reinecke U
    Schmerz; 2019 Oct; 33(5):466-470. PubMed ID: 31478143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cannabinoid Drugs in the Treatment of Psychiatric Disorders - Data from the German Federal Institute for Drugs and Medical Devices].
    Wülfing F; Schmidt-Wolf G; Cremer-Schaeffer P; Priebe K; Schoofs N
    Psychiatr Prax; 2024 Sep; 51(6):315-320. PubMed ID: 38749455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cannabis as Medicine: Safe Use of Special Regulations].
    Cremer-Schaeffer P
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2021 Apr; 56(4):297-302. PubMed ID: 33890261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cannabis for medical purposes-the law of March 2017 and its history].
    Cremer-Schaeffer P; Knöss W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Jul; 62(7):801-805. PubMed ID: 31139838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical use of cannabis products: Lessons to be learned from Israel and Canada.
    Ablin J; Ste-Marie PA; Schäfer M; Häuser W; Fitzcharles MA
    Schmerz; 2016 Feb; 30(1):3-13. PubMed ID: 26767992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of a standardized survey on the medical use of cannabis products in the German-speaking area].
    Schnelle M; Grotenhermen F; Reif M; Gorter RW
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():28-36. PubMed ID: 10575286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany.
    Szejko N; Becher E; Heimann F; Grotenhermen F; Müller-Vahl KR
    Pharmacopsychiatry; 2024 May; 57(3):133-140. PubMed ID: 38471525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Position paper on medical cannabis and cannabis-based medicines in pain medicine].
    Petzke F; Karst M; Gastmeier K; Radbruch L; Steffen E; Häuser W;
    Schmerz; 2019 Oct; 33(5):449-465. PubMed ID: 31541311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Use of Cannabinoids in Critically Ill Patients: A Survey of Intensive Care Physicians in Germany.
    Foadi N; Dos Santos Teixeira L; Fitzner F; Dieck T; Rhein M; Karst M
    Cannabis Cannabinoid Res; 2024 Oct; 9(5):e1433-e1442. PubMed ID: 37669012
    [No Abstract]   [Full Text] [Related]  

  • 18. [Benefits and harms of cannabis-based medicines from the viewpoint of patients with chronic pain and their physicians : A cohort study in three pain centers of the German federal state Saarland].
    Böttge-Wolpers C; Bialas P; Gottschling S; Juckenhöfel S; Konietzke D; Madlinger A; Welsch P; Häuser W
    Schmerz; 2024 Aug; 38(4):241-249. PubMed ID: 36662296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and harms of medical cannabis: a scoping review of systematic reviews.
    Pratt M; Stevens A; Thuku M; Butler C; Skidmore B; Wieland LS; Clemons M; Kanji S; Hutton B
    Syst Rev; 2019 Dec; 8(1):320. PubMed ID: 31823819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs.
    Parmar JR; Forrest BD; Freeman RA
    Res Social Adm Pharm; 2016; 12(4):638-54. PubMed ID: 26443472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.